<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-06-20" modified="2017-03-15" version="176">
<accession>Q14164</accession>
<accession>D3DT78</accession>
<accession>Q3B754</accession>
<accession>Q3KR43</accession>
<accession>Q5JTS6</accession>
<name>IKKE_HUMAN</name>
<protein>
<recommendedName>
<fullName>Inhibitor of nuclear factor kappa-B kinase subunit epsilon</fullName>
<shortName>I-kappa-B kinase epsilon</shortName>
<shortName>IKK-E</shortName>
<shortName>IKK-epsilon</shortName>
<shortName>IkBKE</shortName>
<ecNumber>2.7.11.10</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Inducible I kappa-B kinase</fullName>
<shortName>IKK-i</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">IKBKE</name>
<name type="synonym">IKKE</name>
<name type="synonym">IKKI</name>
<name type="synonym">KIAA0151</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Int. Immunol." volume="11" first="1357" last="1362">
<title>IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases.</title>
<authorList>
<person name="Shimada T."/>
<person name="Kawai T."/>
<person name="Takeda K."/>
<person name="Matsumoto M."/>
<person name="Inoue J."/>
<person name="Tatsumi Y."/>
<person name="Kanamaru A."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="10421793"/>
<dbReference type="DOI" id="10.1093/intimm/11.8.1357"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>MUTAGENESIS OF LYS-38; GLU-168 AND SER-172</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Mol. Cell" volume="5" first="513" last="522">
<title>IKK epsilon is part of a novel PMA-inducible IkappaB kinase complex.</title>
<authorList>
<person name="Peters R.T."/>
<person name="Liao S.-M."/>
<person name="Maniatis T."/>
</authorList>
<dbReference type="PubMed" id="10882136"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)80445-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Leukocyte</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1995" name="DNA Res." volume="2" first="167" last="174">
<title>Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1.</title>
<authorList>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Tanaka A."/>
<person name="Ishikawa K."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="8590280"/>
<dbReference type="DOI" id="10.1093/dnares/2.4.167"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2005-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS LYS-128; THR-371; ASP-515; MET-543; VAL-602 AND LEU-713</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="7780" last="7793">
<title>Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling.</title>
<authorList>
<person name="Fujita F."/>
<person name="Taniguchi Y."/>
<person name="Kato T."/>
<person name="Narita Y."/>
<person name="Furuya A."/>
<person name="Ogawa T."/>
<person name="Sakurai H."/>
<person name="Joh T."/>
<person name="Itoh M."/>
<person name="Delhase M."/>
<person name="Karin M."/>
<person name="Nakanishi M."/>
</authorList>
<dbReference type="PubMed" id="14560022"/>
<dbReference type="DOI" id="10.1128/MCB.23.21.7780-7793.2003"/>
</citation>
<scope>INTERACTION WITH AZI2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15652" last="15661">
<title>Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.</title>
<authorList>
<person name="Han K.J."/>
<person name="Su X."/>
<person name="Xu L.-G."/>
<person name="Bin L.H."/>
<person name="Zhang J."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14739303"/>
<dbReference type="DOI" id="10.1074/jbc.M311629200"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="4018" last="4028">
<title>SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.</title>
<authorList>
<person name="Huang J."/>
<person name="Liu T."/>
<person name="Xu L.-G."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="16281057"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600863"/>
</citation>
<scope>INTERACTION WITH SIKE1; IRF3; TICAM1 AND DDX58</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2005" name="Nature" volume="437" first="1167" last="1172">
<title>Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.</title>
<authorList>
<person name="Meylan E."/>
<person name="Curran J."/>
<person name="Hofmann K."/>
<person name="Moradpour D."/>
<person name="Binder M."/>
<person name="Bartenschlager R."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="16177806"/>
<dbReference type="DOI" id="10.1038/nature04193"/>
</citation>
<scope>INTERACTION WITH MAVS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="3180" last="3190">
<title>SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK.</title>
<authorList>
<person name="Ryzhakov G."/>
<person name="Randow F."/>
</authorList>
<dbReference type="PubMed" id="17568778"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601743"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH AZI2; TANK AND TBKBP1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="11706" last="11711">
<title>Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase.</title>
<authorList>
<person name="Diao F."/>
<person name="Li S."/>
<person name="Tian Y."/>
<person name="Zhang M."/>
<person name="Xu L.G."/>
<person name="Zhang Y."/>
<person name="Wang R.P."/>
<person name="Chen D."/>
<person name="Zhai Z."/>
<person name="Zhong B."/>
<person name="Tien P."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="17600090"/>
<dbReference type="DOI" id="10.1073/pnas.0700544104"/>
</citation>
<scope>INTERACTION WITH IFIH1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2135" last="2146">
<title>The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response.</title>
<authorList>
<person name="Soulat D."/>
<person name="Burckstummer T."/>
<person name="Westermayer S."/>
<person name="Goncalves A."/>
<person name="Bauch A."/>
<person name="Stefanovic A."/>
<person name="Hantschel O."/>
<person name="Bennett K.L."/>
<person name="Decker T."/>
<person name="Superti-Furga G."/>
</authorList>
<dbReference type="PubMed" id="18583960"/>
<dbReference type="DOI" id="10.1038/emboj.2008.126"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF DDX3X</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2147" last="2157">
<title>Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation.</title>
<authorList>
<person name="Schroder M."/>
<person name="Baran M."/>
<person name="Bowie A.G."/>
</authorList>
<dbReference type="PubMed" id="18636090"/>
<dbReference type="DOI" id="10.1038/emboj.2008.143"/>
</citation>
<scope>INTERACTION WITH DDX3X</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="EMBO Rep." volume="9" first="930" last="936">
<title>The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.</title>
<authorList>
<person name="Friedman C.S."/>
<person name="O'Donnell M.A."/>
<person name="Legarda-Addison D."/>
<person name="Ng A."/>
<person name="Cardenas W.B."/>
<person name="Yount J.S."/>
<person name="Moran T.M."/>
<person name="Basler C.F."/>
<person name="Komuro A."/>
<person name="Horvath C.M."/>
<person name="Xavier R."/>
<person name="Ting A.T."/>
</authorList>
<dbReference type="PubMed" id="18636086"/>
<dbReference type="DOI" id="10.1038/embor.2008.136"/>
</citation>
<scope>INTERACTION WITH CYLD</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="J. Virol." volume="83" first="3069" last="3077">
<title>Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.</title>
<authorList>
<person name="Prins K.C."/>
<person name="Cardenas W.B."/>
<person name="Basler C.F."/>
</authorList>
<dbReference type="PubMed" id="19153231"/>
<dbReference type="DOI" id="10.1128/JVI.01875-08"/>
</citation>
<scope>FUNCTION IN IRF3 PHOSPHORYLATION</scope>
<scope>INTERACTION WITH EBOLAVIRUS PROTEIN VP35</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-664</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2010" name="Mol. Cell" volume="37" first="503" last="515">
<title>SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death.</title>
<authorList>
<person name="Renner F."/>
<person name="Moreno R."/>
<person name="Schmitz M.L."/>
</authorList>
<dbReference type="PubMed" id="20188669"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.01.018"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TOPORS</scope>
<scope>SUMOYLATION AT LYS-231 BY TOPORS</scope>
<scope>DESUMOYLATION BY SENP1</scope>
<scope>MUTAGENESIS OF LYS-231</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="PLoS Pathog." volume="6" first="E1000986" last="E1000986">
<title>Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion.</title>
<authorList>
<person name="Wang H."/>
<person name="Ryu W.S."/>
</authorList>
<dbReference type="PubMed" id="20657822"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000986"/>
</citation>
<scope>INTERACTION WITH DDX3X</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="Biochem. J." volume="434" first="93" last="104">
<title>Novel cross-talk within the IKK family controls innate immunity.</title>
<authorList>
<person name="Clark K."/>
<person name="Peggie M."/>
<person name="Plater L."/>
<person name="Sorcek R.J."/>
<person name="Young E.R."/>
<person name="Madwed J.B."/>
<person name="Hough J."/>
<person name="McIver E.G."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="21138416"/>
<dbReference type="DOI" id="10.1042/BJ20101701"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION BY IKBKB/IKKB</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="6474" last="6479">
<title>IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.</title>
<authorList>
<person name="Xie X."/>
<person name="Zhang D."/>
<person name="Zhao B."/>
<person name="Lu M.K."/>
<person name="You M."/>
<person name="Condorelli G."/>
<person name="Wang C.Y."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="21464307"/>
<dbReference type="DOI" id="10.1073/pnas.1016132108"/>
</citation>
<scope>FUNCTION IN AKT PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="J. Virol." volume="86" first="7728" last="7738">
<title>Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon.</title>
<authorList>
<person name="Pythoud C."/>
<person name="Rodrigo W.W."/>
<person name="Pasqual G."/>
<person name="Rothenberger S."/>
<person name="Martinez-Sobrido L."/>
<person name="de la Torre J.C."/>
<person name="Kunz S."/>
</authorList>
<dbReference type="PubMed" id="22532683"/>
<dbReference type="DOI" id="10.1128/JVI.00187-12"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ARENAVIRUS PROTEIN N</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="Cell Rep." volume="3" first="724" last="733">
<title>IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.</title>
<authorList>
<person name="Zhou A.Y."/>
<person name="Shen R.R."/>
<person name="Kim E."/>
<person name="Lock Y.J."/>
<person name="Xu M."/>
<person name="Chen Z.J."/>
<person name="Hahn W.C."/>
</authorList>
<dbReference type="PubMed" id="23453969"/>
<dbReference type="DOI" id="10.1016/j.celrep.2013.01.031"/>
</citation>
<scope>FUNCTION</scope>
<scope>HOMODIMER</scope>
<scope>INTERACTION WITH IKBKB; IKBKG AND MYD88</scope>
<scope>INDUCTION BY LPS</scope>
<scope>UBIQUITINATION AT LYS-30 AND LYS-401</scope>
<scope>MUTAGENESIS OF LYS-30; LYS-401 AND LYS-416</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="2004" last="2015">
<title>Human DEAD box helicase 3 couples IkappaB kinase epsilon to interferon regulatory factor 3 activation.</title>
<authorList>
<person name="Gu L."/>
<person name="Fullam A."/>
<person name="Brennan R."/>
<person name="Schroder M."/>
</authorList>
<dbReference type="PubMed" id="23478265"/>
<dbReference type="DOI" id="10.1128/MCB.01603-12"/>
</citation>
<scope>FUNCTION IN DDX3X AND IRF3 PHOSPHORYLATION</scope>
<scope>INTERACTION WITH DDX3X AND IRF3</scope>
<scope>PHOSPHORYLATION AT SER-172</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Immunity" volume="40" first="880" last="895">
<title>Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKepsilon kinase-mediated antiviral response.</title>
<authorList>
<person name="Rajsbaum R."/>
<person name="Versteeg G.A."/>
<person name="Schmid S."/>
<person name="Maestre A.M."/>
<person name="Belicha-Villanueva A."/>
<person name="Martinez-Romero C."/>
<person name="Patel J.R."/>
<person name="Morrison J."/>
<person name="Pisanelli G."/>
<person name="Miorin L."/>
<person name="Laurent-Rolle M."/>
<person name="Moulton H.M."/>
<person name="Stein D.A."/>
<person name="Fernandez-Sesma A."/>
<person name="tenOever B.R."/>
<person name="Garcia-Sastre A."/>
</authorList>
<dbReference type="PubMed" id="24882218"/>
<dbReference type="DOI" id="10.1016/j.immuni.2014.04.018"/>
</citation>
<scope>INTERACTION WITH TRIM6 AND POLYUBIQUITIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT THR-501</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] THR-371; MET-483; VAL-602; GLU-660 AND LEU-713</scope>
</reference>
<comment type="function">
<text evidence="9 11 14 15 17 18 19 20 21">Serine/threonine kinase that plays an essential role in regulating inflammatory responses to viral infection, through the activation of the type I IFN, NF-kappa-B and STAT signaling. Also involved in TNFA and inflammatory cytokines, like Interleukin-1, signaling. Following activation of viral RNA sensors, such as RIG-I-like receptors, associates with DDX3X and phosphorylates interferon regulatory factors (IRFs), IRF3 and IRF7, as well as DDX3X. This activity allows subsequent homodimerization and nuclear translocation of the IRF3 leading to transcriptional activation of pro-inflammatory and antiviral genes including IFNB. In order to establish such an antiviral state, IKBKE forms several different complexes whose composition depends on the type of cell and cellular stimuli. Thus, several scaffolding molecules including IPS1/MAVS, TANK, AZI2/NAP1 or TBKBP1/SINTBAD can be recruited to the IKBKE-containing-complexes. Activated by polyubiquitination in response to TNFA and interleukin-1, regulates the NF-kappa-B signaling pathway through, at least, the phosphorylation of CYLD. Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. In addition, is also required for the induction of a subset of ISGs which displays antiviral activity, may be through the phosphorylation of STAT1 at 'Ser-708'. Phosphorylation of STAT1 at 'Ser-708' seems also to promote the assembly and DNA binding of ISGF3 (STAT1:STAT2:IRF9) complexes compared to GAF (STAT1:STAT1) complexes, in this way regulating the balance between type I and type II IFN responses. Protects cells against DNA damage-induced cell death. Also plays an important role in energy balance regulation by sustaining a state of chronic, low-grade inflammation in obesity, wich leads to a negative impact on insulin sensitivity. Phosphorylates AKT1.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [I-kappa-B protein] = ADP + [I-kappa-B phosphoprotein].</text>
</comment>
<comment type="subunit">
<text evidence="4 5 6 7 9 10 12 13 14 15 16 19 20 21 22">Homodimer. Interacts with MAVS/IPS1. Interacts with the adapter proteins AZI2/NAP1, TANK and TBKBP1/SINTBAD. Interacts with SIKE1. Interacts with TICAM1/TRIF, IRF3 and DDX58/RIG-I; interactions are disrupted by the interaction between IKBKE and SIKE1. Interacts with TOPORS; induced by DNA damage. Interacts with CYLD. Interacts (when polyubiquitinated) with IKBKB, IKBKG and MYD88. Interacts with IFIH1 (PubMed:17600090). Interacts with DDX3X; the interaction is found to be induced upon virus infection. Interacts (via Protein kinase domain) with arenavirus protein N; the interaction inhibits IKBKE kinase function. Interacts with Ebola virus protein VP35; the interaction leads to inhibition of cellular antiviral response by blocking necessary interactions between the IKBKE and MAVS/IPS as well as its substrates IRF3 and IRF7. Interacts with TRIM6 (via SPRY box) (PubMed:24882218). Interacts with unanchored K48-linked polyubiquitin chains; this leads to IKBKE activation (PubMed:24882218).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-8788634">
<id>K7Y1A2</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-6919131">
<id>P27958</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-743771">
<id>Q92624</id>
<label>APPBP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-353779">
<id>O00571</id>
<label>DDX3X</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-2650369">
<id>Q14653</id>
<label>IRF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-995373">
<id>Q7Z434</id>
<label>MAVS</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-356349">
<id>Q92844</id>
<label>TANK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-356402">
<id>Q9UHD2</id>
<label>TBK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-359969">
<id>A7MCY6</id>
<label>TBKBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-307369"/>
<interactant intactId="EBI-6148294">
<id>Q05127</id>
<label>VP35</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Nucleus</location>
<location evidence="15">PML body</location>
</subcellularLocation>
<text evidence="15 22">Targeting to PML nuclear bodies upon DNA damage is TOPORS-dependent (PubMed:20188669). Located diffusely throughout the cytoplasm but locates to punctate cytoplasmic bodies when coexpressed with TRIM6 (PubMed:24882218).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q14164-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q14164-2</id>
<name>2</name>
<sequence type="described" ref="VSP_044305"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>Highly expressed in spleen followed by thymus, peripheral blood leukocytes, pancreas, placenta. Weakly expressed in lung, kidney, prostate, ovary and colon.</text>
</comment>
<comment type="induction">
<text evidence="20">Induced by lipopolysaccharide (LPS) and TNFA.</text>
</comment>
<comment type="PTM">
<text evidence="17 21">Autophosphorylated and phosphorylated by IKBKB/IKKB. Phosphorylation at Ser-172 is enhanced by the interaction with DDX3X. Phosphorylated at Thr-501 upon IFN activation.</text>
</comment>
<comment type="PTM">
<text evidence="15">Sumoylation by TOPORS upon DNA damage is required for protection of cells against DNA damage-induced cell death. Desumoylated by SENP1.</text>
</comment>
<comment type="PTM">
<text evidence="20">'Lys-63'-linked polyubiquitinated at Lys-30 and Lys-401 by TRAF2:BIRC2 and TRAF2:BIRC3 complexes. Ubiquitination is induced by LPS, TNFA and interleukin-1 and required for full kinase activity and KF-kappa-B pathway activation.</text>
</comment>
<comment type="similarity">
<text evidence="2">Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. I-kappa-B kinase subfamily.</text>
</comment>
<comment type="sequence caution" evidence="25">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA09772" version="2"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ikbke/"/>
</comment>
<dbReference type="EC" id="2.7.11.10"/>
<dbReference type="EMBL" id="D63485">
<property type="protein sequence ID" value="BAA09772.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB016590">
<property type="protein sequence ID" value="BAA85155.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF241789">
<property type="protein sequence ID" value="AAF45307.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ667176">
<property type="protein sequence ID" value="ABG25921.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL354681">
<property type="protein sequence ID" value="CAI15250.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471100">
<property type="protein sequence ID" value="EAW93549.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC105923">
<property type="protein sequence ID" value="AAI05924.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC105924">
<property type="protein sequence ID" value="AAI05925.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC107812">
<property type="protein sequence ID" value="AAI07813.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30996.1">
<molecule id="Q14164-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS53464.1">
<molecule id="Q14164-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180250.1">
<molecule id="Q14164-2"/>
<property type="nucleotide sequence ID" value="NM_001193321.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180251.1">
<property type="nucleotide sequence ID" value="NM_001193322.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_054721.1">
<molecule id="Q14164-1"/>
<property type="nucleotide sequence ID" value="NM_014002.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005273413.1">
<molecule id="Q14164-1"/>
<property type="nucleotide sequence ID" value="XM_005273356.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.321045"/>
<dbReference type="ProteinModelPortal" id="Q14164"/>
<dbReference type="SMR" id="Q14164"/>
<dbReference type="BioGrid" id="115000">
<property type="interactions" value="70"/>
</dbReference>
<dbReference type="DIP" id="DIP-27530N"/>
<dbReference type="IntAct" id="Q14164">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="MINT" id="MINT-1132084"/>
<dbReference type="STRING" id="9606.ENSP00000356087"/>
<dbReference type="BindingDB" id="Q14164"/>
<dbReference type="ChEMBL" id="CHEMBL3529"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2040"/>
<dbReference type="iPTMnet" id="Q14164"/>
<dbReference type="PhosphoSitePlus" id="Q14164"/>
<dbReference type="BioMuta" id="IKBKE"/>
<dbReference type="DMDM" id="14548079"/>
<dbReference type="EPD" id="Q14164"/>
<dbReference type="MaxQB" id="Q14164"/>
<dbReference type="PaxDb" id="Q14164"/>
<dbReference type="PeptideAtlas" id="Q14164"/>
<dbReference type="PRIDE" id="Q14164"/>
<dbReference type="DNASU" id="9641"/>
<dbReference type="Ensembl" id="ENST00000581977">
<molecule id="Q14164-1"/>
<property type="protein sequence ID" value="ENSP00000464030"/>
<property type="gene ID" value="ENSG00000263528"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000584998">
<molecule id="Q14164-2"/>
<property type="protein sequence ID" value="ENSP00000462396"/>
<property type="gene ID" value="ENSG00000263528"/>
</dbReference>
<dbReference type="GeneID" id="9641"/>
<dbReference type="KEGG" id="hsa:9641"/>
<dbReference type="UCSC" id="uc001hdz.3">
<molecule id="Q14164-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9641"/>
<dbReference type="DisGeNET" id="9641"/>
<dbReference type="GeneCards" id="IKBKE"/>
<dbReference type="H-InvDB" id="HIX0116011"/>
<dbReference type="HGNC" id="HGNC:14552">
<property type="gene designation" value="IKBKE"/>
</dbReference>
<dbReference type="HPA" id="CAB025983"/>
<dbReference type="HPA" id="HPA015788"/>
<dbReference type="MIM" id="605048">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q14164"/>
<dbReference type="OpenTargets" id="ENSG00000263528"/>
<dbReference type="PharmGKB" id="PA134962294"/>
<dbReference type="eggNOG" id="KOG4250">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XRMU">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00820000127009"/>
<dbReference type="HOGENOM" id="HOG000220867"/>
<dbReference type="HOVERGEN" id="HBG008494"/>
<dbReference type="InParanoid" id="Q14164"/>
<dbReference type="KO" id="K07211"/>
<dbReference type="OMA" id="CCLDKMY"/>
<dbReference type="OrthoDB" id="EOG091G0354"/>
<dbReference type="PhylomeDB" id="Q14164"/>
<dbReference type="TreeFam" id="TF324269"/>
<dbReference type="BRENDA" id="2.7.11.10">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-918233">
<property type="pathway name" value="TRAF3-dependent IRF activation pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933541">
<property type="pathway name" value="TRAF6 mediated IRF7 activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936440">
<property type="pathway name" value="Negative regulators of RIG-I/MDA5 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936964">
<property type="pathway name" value="Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q14164"/>
<dbReference type="SignaLink" id="Q14164"/>
<dbReference type="SIGNOR" id="Q14164"/>
<dbReference type="ChiTaRS" id="IKBKE">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="IKBKE"/>
<dbReference type="GenomeRNAi" id="9641"/>
<dbReference type="PRO" id="PR:Q14164"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000143466"/>
<dbReference type="CleanEx" id="HS_IKBKE"/>
<dbReference type="ExpressionAtlas" id="Q14164">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q14164">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031966">
<property type="term" value="C:mitochondrial membrane"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016605">
<property type="term" value="C:PML body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008384">
<property type="term" value="F:IkappaB kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0036435">
<property type="term" value="F:K48-linked polyubiquitin binding"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004704">
<property type="term" value="F:NF-kappaB-inducing kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098586">
<property type="term" value="P:cellular response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008630">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032480">
<property type="term" value="P:negative regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010884">
<property type="term" value="P:positive regulation of lipid storage"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051260">
<property type="term" value="P:protein homooligomerization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035456">
<property type="term" value="P:response to interferon-beta"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034340">
<property type="term" value="P:response to type I interferon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Inhibitor of nuclear factor kappa-B kinase subunit epsilon" id="PRO_0000086017">
<location>
<begin position="1"/>
<end position="716"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="2">
<location>
<begin position="9"/>
<end position="315"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="2">
<location>
<begin position="15"/>
<end position="23"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with DDX3X">
<location>
<begin position="383"/>
<end position="647"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper">
<location>
<begin position="436"/>
<end position="457"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="2">
<location>
<position position="135"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="25">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis and IKKB" evidence="21">
<location>
<position position="172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="22">
<location>
<position position="501"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="664"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="20">
<location>
<position position="30"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="15">
<location>
<position position="231"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="20">
<location>
<position position="401"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044305" evidence="24">
<location>
<begin position="1"/>
<end position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41296028." id="VAR_038816" evidence="23">
<original>E</original>
<variation>K</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17021877." id="VAR_038817" evidence="8 23">
<original>A</original>
<variation>T</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs52817862." id="VAR_040571" evidence="8">
<original>T</original>
<variation>M</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41299015." id="VAR_038818" evidence="23">
<original>E</original>
<variation>D</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs41299037." id="VAR_038819" evidence="23">
<original>I</original>
<variation>M</variation>
<location>
<position position="543"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12059562." id="VAR_038820" evidence="8 23">
<original>A</original>
<variation>V</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55822317." id="VAR_040572" evidence="8">
<original>G</original>
<variation>E</variation>
<location>
<position position="660"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3748022." id="VAR_019989" evidence="8 23">
<original>P</original>
<variation>L</variation>
<location>
<position position="713"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitination and decreased kinase activity. No effect on homodimerization." evidence="20">
<original>K</original>
<variation>A</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization." evidence="20">
<original>K</original>
<variation>R</variation>
<location>
<position position="30"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity and loss of nuclear import." evidence="3">
<original>K</original>
<variation>A</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight decrease of kinase activity." evidence="3">
<original>E</original>
<variation>A</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of autophosphorylation and of kinase activity." evidence="3">
<original>S</original>
<variation>A</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in kinase activity." evidence="3">
<original>S</original>
<variation>E</variation>
<location>
<position position="172"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sumoylation and loss of targeting to nuclear bodies." evidence="15">
<original>K</original>
<variation>R</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitination and decreased kinase activity. No effect on homodimerization." evidence="20">
<original>K</original>
<variation>A</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization." evidence="20">
<original>K</original>
<variation>R</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ubiquitination." evidence="20">
<original>K</original>
<variation>A</variation>
<location>
<position position="416"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ubiquitination." evidence="20">
<original>K</original>
<variation>R</variation>
<location>
<position position="416"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAI05925." ref="7" evidence="25">
<original>R</original>
<variation>Q</variation>
<location>
<position position="187"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10421793"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14560022"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14739303"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16177806"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16281057"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17568778"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17600090"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18583960"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18636086"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18636090"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19153231"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20188669"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20657822"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21138416"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21464307"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22532683"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23453969"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23478265"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24882218"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="24" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<sequence length="716" mass="80462" checksum="3E5FBE5840734D81" modified="1996-11-01" version="1">
MQSTANYLWHTDDLLGQGATASVYKARNKKSGELVAVKVFNTTSYLRPREVQVREFEVLR
KLNHQNIVKLFAVEETGGSRQKVLVMEYCSSGSLLSVLESPENAFGLPEDEFLVVLRCVV
AGMNHLRENGIVHRDIKPGNIMRLVGEEGQSIYKLTDFGAARELDDDEKFVSVYGTEEYL
HPDMYERAVLRKPQQKAFGVTVDLWSIGVTLYHAATGSLPFIPFGGPRRNKEIMYRITTE
KPAGAIAGAQRRENGPLEWSYTLPITCQLSLGLQSQLVPILANILEVEQAKCWGFDQFFA
ETSDILQRVVVHVFSLSQAVLHHIYIHAHNTIAIFQEAVHKQTSVAPRHQEYLFEGHLCV
LEPSVSAQHIAHTTASSPLTLFSTAIPKGLAFRDPALDVPKFVPKVDLQADYNTAKGVLG
AGYQALRLARALLDGQELMFRGLHWVMEVLQATCRRTLEVARTSLLYLSSSLGTERFSSV
AGTPEIQELKAAAELRSRLRTLAEVLSRCSQNITETQESLSSLNRELVKSRDQVHEDRSI
QQIQCCLDKMNFIYKQFKKSRMRPGLGYNEEQIHKLDKVNFSHLAKRLLQVFQEECVQKY
QASLVTHGKRMRVVHETRNHLRLVGCSVAACNTEAQGVQESLSKLLEELSHQLLQDRAKG
AQASPPPIAPYPSPTRKDLLLHMQELCEGMKLLASDLLDNNRIIERLNRVPAPPDV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>